menu
    • menu
    [{"orgOrder":0,"company":"Adcock Ingram","sponsor":"Natco Pharma","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"SOUTH AFRICA","productType":"Miscellaneous","year":"2025","type":"Acquisition","leadProduct":"Paracetamol","moa":"Anandamide amidohydrolase | Cyclooxygenase | Vanilloid receptor","graph1":"Undisclosed","graph2":"Approved FDF","graph3":"Adcock Ingram","amount2":0.23000000000000001,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Syrup","sponsorNew":"Adcock Ingram \/ Natco Pharma","highestDevelopmentStatusID":"15","companyTruncated":"Adcock Ingram \/ Natco Pharma"}]

    Find Clinical Drug Pipeline Developments & Deals by Adcock Ingram

    Menu

    Adcock Ingram

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Adcock Ingram

                            South Africa arrow
                            BOS Manchester
                            Not Confirmed

                            Adcock Ingram

                            South Africa arrow
                            BOS Manchester
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Paracetamol

                            Therapeutic Area : Neurology

                            Study Phase : Approved FDF

                            Sponsor : Natco Pharma

                            Deal Size : $226.0 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Natco Pharma Acquires 35.75% Stake in Adcock Ingram for US$ 226 Million

                            Details : Through the acquisition of Paracetamol, the deal aims to advance the development of targeting Anandamide amidohydrolase, Cyclooxygenase, and Vanilloid receptor.

                            Product Name : Panado

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            November 13, 2025

                            Lead Product(s) : Paracetamol

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved FDF

                            Sponsor : Natco Pharma

                            Deal Size : $226.0 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth